DD8-18609-21936
2 vaccinations
3 coded responses
22 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 936 / CA
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Pfizer-BioNTech
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-17
Survey response — day 14, dose 1MedDRA: Chills, Hyperhidrosis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Chills and sweats.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-23
Dose 2 — Pfizer-BioNTech
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Pain of skin, Sensitive skin — Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Hurts to touch my skin. Overly sensitive all overMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-28
- 2021-03-07
- 2021-07-24
-
2022-01-23
Survey response — 12 months, dose 2MedDRA: Cough, Fatigue, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough, chest congestion. Stuffy head, fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-23
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-26
- 2022-01-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-23 | Pfizer-BioNTech |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 14, dose 1
Symptoms: Chills and sweats.
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Hurts to touch my skin. Overly sensitive all over
Release 11 — 12 months, dose 2
Symptoms: Cough, chest congestion. Stuffy head, fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hyperhidrosis | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Pain of skin | ✓ | ✓ | ✓ |
| SRO | Sensitive skin | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release